ZEULIDE DEPOT DIN 02429977
Health Canada record
| Active ingredient(s) | LEUPROLIDE ACETATE 3.75 MG |
|---|---|
| Dosage form | Kit; Powder For Suspension (Sustained-Release |
| Route | Intramuscular |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L02AE02 LEUPRORELIN |
| Original market date | 08-Oct-2019 |
| Current status date | 08-Oct-2019 |
| Source | Health Canada DPD |
Establishment licence of the holder
Verity Pharmaceuticals Inc. — licence 3-002542, currently licensed, last inspection rating C (2023-12-19).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LEUPROLIDE ACETATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02248999 | ELIGARD | TOLMAR INTERNATIONAL LTD. | Powder For Suspension (Sustained-Release | LEUPROLIDE ACETATE 30 MG | Marketed |
| 02268892 | ELIGARD | TOLMAR INTERNATIONAL LTD. | Powder For Suspension (Sustained-Release | LEUPROLIDE ACETATE 45 MG | Marketed |
| 02248240 | ELIGARD | TOLMAR INTERNATIONAL LTD. | Powder For Suspension (Sustained-Release | LEUPROLIDE ACETATE 22.5 MG | Marketed |
| 02248239 | ELIGARD | TOLMAR INTERNATIONAL LTD. | Powder For Suspension (Sustained-Release | LEUPROLIDE ACETATE 7.5 MG | Marketed |
| 02239833 | LUPRON DEPOT | ABBVIE CORPORATION | Powder For Suspension (Sustained-Release | LEUPROLIDE ACETATE 30 MG | Marketed |
| 02239834 | LUPRON DEPOT | ABBVIE CORPORATION | Powder For Suspension (Sustained-Release | LEUPROLIDE ACETATE 11.25 MG | Marketed |
| 02562855 | LUPRON DEPOT | ABBVIE CORPORATION | Powder For Suspension (Sustained-Release | LEUPROLIDE ACETATE 45 MG | Marketed |
| 00836273 | LUPRON DEPOT | ABBVIE CORPORATION | Powder For Suspension (Sustained-Release | LEUPROLIDE ACETATE 7.5 MG | Marketed |
| 00884502 | LUPRON DEPOT | ABBVIE CORPORATION | Powder For Suspension (Sustained-Release | LEUPROLIDE ACETATE 3.75 MG | Marketed |
| 02230248 | LUPRON DEPOT | ABBVIE CORPORATION | Powder For Suspension (Sustained-Release | LEUPROLIDE ACETATE 22.5 MG | Marketed |
| 02462699 | ZEULIDE DEPOT | VERITY PHARMACEUTICALS INC. | Kit; Powder For Suspension (Sustained-Release | LEUPROLIDE ACETATE 22.5 MG | Marketed |
| 02240264 | LEUPROLIDE ACETATE INJECTION | NOVOPHARM LIMITED | Liquid | LEUPROLIDE ACETATE 5 MG | Cancelled Pre Market |
| 00727695 | LUPRON | ABBVIE CORPORATION | Solution | LEUPROLIDE ACETATE 5 MG | Cancelled Post Market |
| 02148730 | LUPRON DEPOT | ABBVIE CORPORATION | Powder For Suspension (Sustained-Release | LEUPROLIDE ACETATE 15 MG | Cancelled Pre Market |
| 02148722 | LUPRON DEPOT | ABBVIE CORPORATION | Powder For Suspension (Sustained-Release | LEUPROLIDE ACETATE 11.25 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 22414 | 2019-07-17 | New Drug Submission (NDS) | CHANGE IN PRODUCT OWNERSHIP |
| 15946 | 2014-08-15 | New Drug Submission (NDS) |
International API supply for LEUPROLIDE ACETATE
13 active FDA Drug Master Files.
Request a quote for ZEULIDE DEPOT